About Vitas Pharma
Vitas Pharma is a Healthcare company based in Hyderabad (India) founded in 2011 by Rajinder Kumar and Radha Rangarajan. An Indian preclinical-stage biopharma developing small molecule therapeutics for MDR bacterial infections. It operates on a B2B model. Vitas Pharma has raised $484.45 thousand across 1 funding round from investors including Broadridge, GrayCell Ventures and Deep Kalra. Vitas Pharma was last valued at $2.41 million in January 2015. Its chief executive, as recorded, is Radha Rangarajan. Its Indian entity Vitas Pharma Research Private Limited reported revenue of ₹1.07 Cr. Its focus areas include Biopharmaceuticals, Drug Development and Infectious Disease Therapeutics.
Company details
Vitas Pharma operates with a B2B model, focusing on providing healthcare solutions, biopharmaceuticals, drug development, and infectious disease therapeutics. An Indian preclinical-stage biopharma developing small molecule therapeutics for MDR bacterial infections. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Hyderabad, India
- Founders Rajinder Kumar, Radha Rangarajan
- Stage Minicorn
- SectorsHealthcare
- Website vitaspharma.com
- Legal Name Vitas Pharma Research Private Limited
- Date of Incorporation 07 Jun, 2010
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.07 Cr
FY 2020 · +32% YoY
- Net Loss-₹3.44 Cr
FY 2020 · -321% margin
- EBITDA-₹3.44 Cr
FY 2020 · -320% margin
- Total Equity Funding$484.45K (USD)
in 1 rounds
- Latest Funding Round$484.45K (USD), Seed
Jan 2015
- InvestorsBroadridge
& 43 more
Associated legal entities of Vitas Pharma
Vitas Pharma operates through Vitas Pharma Research Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vitas Pharma Research Private Limited CIN U73100TG2010PTC068813 | Strike Off | 07 Jun 2010 | Hyderabad, Telangana | ₹1.1 Cr | 2 | View details |
Funding Insights of Vitas Pharma
Vitas Pharma has successfully raised a total of $484.45K through 1 strategic funding round. The most recent funding activity was a Seed round of $484.45 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $484,452
- Total Rounds 1
- Last Round Seed — $484,452
- First Round $484,452
(Jan 2015)
- Investors Count 43
All 1 funding rounds of Vitas Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $484,452 | Seed | $2.41M | Hemant Kanakia |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2015 | $2.41M | •••••••• |
Last known valuation $2.41M (Jan 2015). 44 investors in total: 9 institutional and 35 angel.
Investors in Vitas Pharma
Vitas Pharma has secured backing from 44 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Broadridge, GrayCell Ventures and Deep Kalra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel network focused on India, Singapore, and U.S based companies | sgan.sg | Singapore, Singapore | ||
Angel investor network investing in early-stage startups | iangroup.vc | Delhi, India | ||
Technology company focused on building bonds through software. | 2012 | graycellventures.com | Chandigarh, India | |
Limited information available | Delhi, India | |||
Early stage investments are made in innovative Indian startups. | 2006 | indianangelnetwork.com | New Delhi, India | |
Cloud-based accounting and financial management solutions are offered to businesses. | 2007 | broadridge.com | New York, United States | |
Trading and finance activities are conducted in Delhi, India. | Delhi, India | |||
Corporate advisory services are offered across multiple sectors. | Delhi, India | |||
DK Deep Kalra | Founder of MakeMyTrip, prominent angel investor in Indian startups | unknown_14cea0787da34ea7a | ||
AM Alok Mittal | Co-founder of Indifi, angel investor, ex-Canaan Partners, startup mentor | unknown_0269e9f171924049b |
Investor details for Vitas Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vitas Pharma Research Private Limited (Vitas Pharma)
Vitas Pharma Research Private Limited is the primary company behind Vitas Pharma. The board of Vitas Pharma Research Private Limited currently have 2 directors; the longest-serving is Rajinder Kumar, appointed in 2010. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajinder Kumar DIN 02957318 | Director | 07 Jun 2010 | 16 yrs 5 mo | Vitas Pharma Research Private Limited |
| Radha Rangarajan DIN 02956562 | Managing Director | 07 Jun 2010 | 16 yrs 5 mo | Vitas Pharma Research Private Limited |
People of Vitas Pharma
2 people are tracked at Vitas Pharma (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, CMO | Leadership | |
| Founder, CEO | Leadership |
Complete people profiles for Vitas Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vitas Pharma
Figures of Vitas Pharma Research Private Limited, the primary company behind Vitas Pharma, for FY 2020. Revenue was ₹1.07 Cr (+32% year on year). Net loss was -₹3.44 Cr (-321% margin). EBITDA was -₹3.44 Cr (-320% margin). Revenue has grown at a compounded annual rate of +735% over three years and +13% over five years.
- ₹1.07 CrRevenue · FY 2020 · +32% YoY
- -₹3.44 CrNet loss · -321% margin
- -₹3.44 CrEBITDA · -320% margin
- ₹52.8 LakhPaid-up capital
- +735%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vitas Pharma Research Private Limited are on its company page.
Detailed financial statements for Vitas Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Vitas Pharma
3 dated milestones of Vitas Pharma across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Vitas Pharma is founded.
- Funding First funding round of $484K.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vitas Pharma
Vitas Pharma was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Vitas Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Radha Rangarajan is the CEO of Vitas Pharma, as recorded in our data. They have also founded this company.
Vitas Pharma is a funded company, having raised a total of $484.45K across 1 funding round to date. The company's 1st funding round was a Seed of $484.45K, raised on Jan 2015.
The primary company behind Vitas Pharma, Vitas Pharma Research Private Limited, reported revenue of ₹1.07 Cr for FY 2020, up 32% year on year.
Vitas Pharma operates with a B2B model, focusing on providing healthcare solutions, biopharmaceuticals, drug development, and infectious disease therapeutics. An Indian preclinical-stage biopharma developing small molecule therapeutics for MDR bacterial infections. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Vitas Pharma has 44 investors. Key investors include Broadridge, GrayCell Ventures, Deep Kalra, Alok Mittal, and Sujan Parikh.
The valuation of Vitas Pharma is $2.41M as of Jan 2015.
Vitas Pharma operates through Vitas Pharma Research Private Limited.
The legal entities of Vitas Pharma currently have 2 directors, including Rajinder Kumar, Radha Rangarajan.